151 related articles for article (PubMed ID: 31375304)
1. Efficacy analysis of medical and surgical treatments in chronic kidney disease patients with secondary hyperparathyroidism.
Huang Y; Wu H; Wu Y; Luo Z
Am J Otolaryngol; 2019; 40(6):102228. PubMed ID: 31375304
[TBL] [Abstract][Full Text] [Related]
2. Long-term mortality after parathyroidectomy among chronic kidney disease patients with secondary hyperparathyroidism: a systematic review and meta-analysis.
Chen L; Wang K; Yu S; Lai L; Zhang X; Yuan J; Duan W
Ren Fail; 2016 Aug; 38(7):1050-8. PubMed ID: 27198474
[TBL] [Abstract][Full Text] [Related]
3. Pharmaceutical Management of Secondary Hyperparathyroidism and the Role of Surgery: A 5-Year Retrospective Study.
Sevva C; Divanis D; Tsinari A; Grammenos P; Laskou S; Mantalobas S; Paschou E; Magra V; Kopsidas P; Kesisoglou I; Liakopoulos V; Sapalidis K
Medicina (Kaunas); 2024 May; 60(5):. PubMed ID: 38792994
[No Abstract] [Full Text] [Related]
4. Evaluation of Parathyroidectomy for Secondary and Tertiary Hyperparathyroidism by the Parathyroid Surgeons' Society of Japan.
Tominaga Y; Kakuta T; Yasunaga C; Nakamura M; Kadokura Y; Tahara H
Ther Apher Dial; 2016 Feb; 20(1):6-11. PubMed ID: 26879490
[TBL] [Abstract][Full Text] [Related]
5. The effectiveness of cinacalcet: a randomized, open label study in chronic hemodialysis patients with severe secondary hyperparathyroidism.
Susantitaphong P; Vadcharavivad S; Susomboon T; Singhan W; Dumrongpisutikul N; Jakchairoongruang K; Eiam-Ong S; Praditpornsilpa K
Ren Fail; 2019 Nov; 41(1):326-333. PubMed ID: 31014177
[TBL] [Abstract][Full Text] [Related]
6. Calcimimetics versus parathyroidectomy: What is preferable?
Rroji M; Spasovski G
Int Urol Nephrol; 2018 Jul; 50(7):1271-1275. PubMed ID: 29532306
[TBL] [Abstract][Full Text] [Related]
7. A Randomized Study Comparing Parathyroidectomy with Cinacalcet for Treating Hypercalcemia in Kidney Allograft Recipients with Hyperparathyroidism.
Cruzado JM; Moreno P; Torregrosa JV; Taco O; Mast R; Gómez-Vaquero C; Polo C; Revuelta I; Francos J; Torras J; García-Barrasa A; Bestard O; Grinyó JM
J Am Soc Nephrol; 2016 Aug; 27(8):2487-94. PubMed ID: 26647424
[TBL] [Abstract][Full Text] [Related]
8. Parathyroidectomy in the Management of Secondary Hyperparathyroidism.
Lau WL; Obi Y; Kalantar-Zadeh K
Clin J Am Soc Nephrol; 2018 Jun; 13(6):952-961. PubMed ID: 29523679
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of Cinacalcet in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism Not Receiving Dialysis.
Pérez-Ricart A; Galicia-Basart M; Alcalde-Rodrigo M; Segarra-Medrano A; Suñé-Negre JM; Montoro-Ronsano JB
PLoS One; 2016; 11(9):e0161527. PubMed ID: 27588942
[TBL] [Abstract][Full Text] [Related]
10. Etelcalcetide: injectable calcimimetic for the treatment of secondary hyperparathyroidism in hemodialysis-dependent patients.
Ureña Torres PA; Bover J; Cohen-Solal M
Drugs Today (Barc); 2017 Sep; 53(9):489-500. PubMed ID: 29238762
[TBL] [Abstract][Full Text] [Related]
11. The impact of cinacalcet in the mineral metabolism markers of patients on dialysis with severe secondary hyperparathyroidism.
Bucharles SGE; Barreto FC; Riella MC
J Bras Nefrol; 2019 Jul; 41(3):336-344. PubMed ID: 31419274
[TBL] [Abstract][Full Text] [Related]
12. Cinacalcet versus Parathyroidectomy in the Treatment of Secondary Hyperparathyroidism Post Renal Transplantation.
Soliman AR; Maamoun HA; Soliman MA; Darwish H; Elbanna E
Rom J Intern Med; 2016 Sep; 54(3):184-189. PubMed ID: 27658167
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes of parathyroidectomy versus cinacalcet in the clinical management of secondary hyperparathyroidism.
Kim WW; Rhee Y; Kim BS; Kim K; Lee CR; Kang SW; Lee J; Jeong JJ; Nam KH; Chung WY
Endocr J; 2019 Oct; 66(10):881-889. PubMed ID: 31189770
[TBL] [Abstract][Full Text] [Related]
14. PTH-dependence of the effectiveness of cinacalcet in hemodialysis patients with secondary hyperparathyroidism.
Akizawa T; Kurita N; Mizobuchi M; Fukagawa M; Onishi Y; Yamaguchi T; Ellis AR; Fukuma S; Alan Brookhart M; Hasegawa T; Kurokawa K; Fukuhara S
Sci Rep; 2016 Apr; 6():19612. PubMed ID: 27071541
[TBL] [Abstract][Full Text] [Related]
15. Use of cinacalcet for the management of hyperparathyroidism in patients with different degrees of renal failure.
Orellana JM; Esteban RJ; Castilla YA; Fernández-Castillo R; Nozal-Fernández G; Esteban MA; García-Valverde M; Bravo J
Nefrologia; 2016; 36(2):121-5. PubMed ID: 26906451
[TBL] [Abstract][Full Text] [Related]
16. Decreasing Surgical Management of Secondary Hyperparathyroidism in the United States.
Fligor SC; Li C; Hamaguchi R; William J; James BC
J Surg Res; 2021 Aug; 264():444-453. PubMed ID: 33848844
[TBL] [Abstract][Full Text] [Related]
17. Kidney Disease Improving Global Outcomes guidelines and parathyroidectomy for renal hyperparathyroidism.
Oltmann SC; Madkhali TM; Sippel RS; Chen H; Schneider DF
J Surg Res; 2015 Nov; 199(1):115-20. PubMed ID: 25982045
[TBL] [Abstract][Full Text] [Related]
18. Outcomes in patients with renal hyperparathyroidism requiring cinacalcet pre-operatively followed by parathyroidectomy.
Baker D; Sevak S; Callahan RE; Czako PF; Lloyd LR; Nagar S
Am J Surg; 2019 Jan; 217(1):146-151. PubMed ID: 29929906
[TBL] [Abstract][Full Text] [Related]
19. Paricalcitol- or cinacalcet-centred therapy affects markers of bone mineral disease in patients with secondary hyperparathyroidism receiving haemodialysis: results of the IMPACT-SHPT study.
Cozzolino M; Ketteler M; Martin KJ; Sharma A; Goldsmith D; Khan S
Nephrol Dial Transplant; 2014 Apr; 29(4):899-905. PubMed ID: 24500308
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of parathyroidectomy versus calcimimetics for secondary hyperparathyroidism and kidney transplantation: a propensity-matched analysis.
Koh EY; van der Plas WY; Dulfer RR; Pol RA; Kruijff S; Rotmans JI; Appelman-Dijkstra N; Schepers A; de Borst MH; Hoorn EJ; van Ginhoven TM; Nieveen van Dijkum EJM; Vogt L; Engelsman AF;
Langenbecks Arch Surg; 2020 Sep; 405(6):851-859. PubMed ID: 32778916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]